Pfizer’s Obesity Pipeline Poised to Challenge Novo Nordisk
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
Explore zero based budgeting practices among families, focusing on habits that sustain discipline, transparency, and ongoing adjustment.
21,236 articlesPfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
In this stock market today, june update, airlines surged as fuel prices fell, sparking a technical breakout. American...
AI-driven data centers are fueling a power supercycle, pushing on-site generation and turbocharging turbine prices. G...
When MoonLake Immunotherapeutics announced a larger-than-expected secondary offering, the stock wilted. This guide br...
If you want broad exposure to the U.S. stock market without paying hefty fees, two giants dominate the scene. This gu...
A recent talent exodus rattled Alphabet, but the long-term AI moat, cloud momentum, and strong cash flow argue for pa...
As 2026 unfolds, investors face a choice between two very different travel giants. One leans on software and hosts to...
Bright MLS will begin feeding its broker listings into Google search results via HouseCanary ComeHome, expanding how ...
Rocket Lab just hit a new speed record with its Victus Haze mission, signaling potential shifts in the space-launch m...
A major share sale by Orbimed Advisors in Enliven Therapeutics coincides with a sharp stock rally. This guide breaks ...
A small regional insurer with a long dividend track record is drawing attention for its roughly 4.4% yield as retiree...
As markets wobble and political headwinds rise, a growing chorus argues that ceos have forgotten moderate. This piece...